Stock Earnings

Question 1

What are Cellectis SA's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Cellectis SA has a total asset of $383, Net loss of $-36

Question 2

What are the key financial ratios for CLLS?

Accepted Answer

Cellectis SA's Current ratio is 1.51, has a Net margin is -73.46, sales per share of $0.54.

Question 3

How is Cellectis SA's revenue broken down by segment or geography?

Accepted Answer

Cellectis SA largest revenue segment is Therapeutics, at a revenue of 38,370,486 in the most earnings release.For geography, France is the primary market for Cellectis SA, at a revenue of 38,370,486.

Question 4

Is Cellectis SA profitable?

Accepted Answer

no, according to the latest financial statements, Cellectis SA has a net loss of $-36

Question 5

Does Cellectis SA have any liabilities?

Accepted Answer

yes, Cellectis SA has liability of 252

Question 6

How many outstanding shares for Cellectis SA?

Accepted Answer

Cellectis SA has a total outstanding shares of 72.09

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	112	49	9	25	38	59
Revenue Growth (YoY)	155%	444%	-64%	-34%	-36%	168%
Cost of Revenue	--	45	39	44	66	46
Gross Profit	--	3	-30	-18	-27	13
Selling, General & Admin	14	8	10	10	12	38
Research & Development	65	34	37	42	49	6
Operating Expenses	163	62	66	70	76	55
Other Non Operating Income (Expenses)	--	0	-1	-12	0	0
Pretax Income	-76	-36	-116	-98	-96	-53
Income Tax Expense	0	0	0	0	0	0
Net Income	-76	-36	-101	-106	-114	-81
Net Income Growth	-22%	-64%	-5%	-7%	41%	-21%
Shares Outstanding (Diluted)	101.7	90.56	57.01	45.54	44.82	42.5
Shares Change (YoY)	2%	59%	25%	2%	5%	0%
EPS (Diluted)	-0.76	-0.4	-1.77	-2.33	-2.54	-1.9
EPS Growth	-21%	-77%	-24%	-8%	34%	-21%
Free Cash Flow	--	19	-25	-89	-124	-133
Free Cash Flow Per Share	--	0.2	-0.43	-1.95	-2.76	-3.12
Gross Margin	--	6.12%	-333.33%	-72%	-71.05%	22.03%
Operating Margin	-45.53%	-120.4%	-1,077.77%	-356%	-271.05%	-71.18%
Profit Margin	-67.85%	-73.46%	-1,122.22%	-424%	-300%	-137.28%
Free Cash Flow Margin	--	38.77%	-277.77%	-356%	-326.31%	-225.42%
EBITDA	--	-40	-79	-71	-87	-33
EBITDA Margin	--	-81.63%	-877.77%	-284%	-228.94%	-55.93%
D&A For EBITDA	--	19	18	18	16	9
EBIT	-51	-59	-97	-89	-103	-42
EBIT Margin	-45.53%	-120.4%	-1,077.77%	-356%	-271.05%	-71.18%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Cellectis SA (CLLS) Price

CLLS Stock Price Chart

CLLS Income

Follow-Up Questions